ImportRefusal LogoImportRefusal

MSD PHARMACEUTICAL PVT LTD

⚠️ High Risk

FEI: 3016910456 • Bengaluru • INDIA

FEI

FEI Number

3016910456

📍

Location

Bengaluru

🇮🇳

Country

INDIA
🏢

Address

Khala No 845/713 And 11, , Bengaluru, , India

High Risk

FDA Import Risk Assessment

64.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

9
Total Refusals
1
Unique Violations
3/4/2025
Latest Refusal
7/6/2022
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
37.0×30%
Recency
68.7×20%
Frequency
33.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

759×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
3/4/2025
61PDY68SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/17/2024
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/14/2024
61PDY68SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/23/2024
61PCE68SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/23/2024
61PCE31GLIMEPIRIDE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/23/2024
61PCE26METFORMIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/1/2023
61PDA68SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/23/2022
61PCY68SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
75UNAPPROVED
Division of Northern Border Imports (DNBI)
7/6/2022
61PDY26METFORMIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Northern Border Imports (DNBI)

Frequently Asked Questions

What is MSD PHARMACEUTICAL PVT LTD's FDA import refusal history?

MSD PHARMACEUTICAL PVT LTD (FEI: 3016910456) has 9 FDA import refusal record(s) in our database, spanning from 7/6/2022 to 3/4/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. MSD PHARMACEUTICAL PVT LTD's FEI number is 3016910456.

What types of violations has MSD PHARMACEUTICAL PVT LTD received?

MSD PHARMACEUTICAL PVT LTD has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about MSD PHARMACEUTICAL PVT LTD come from?

All FDA import refusal data for MSD PHARMACEUTICAL PVT LTD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.